{"id":"immulina-tm","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"While specific mechanistic details are limited in public literature, Immulina TM appears to function as an immunomodulatory therapy developed at the University of Mississippi Medical Center. The drug is currently in Phase 3 clinical development, suggesting it has demonstrated preliminary efficacy and safety in earlier trial phases.","oneSentence":"Immulina TM is an immunotherapeutic agent designed to enhance immune system function and modulate immune responses.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:15:46.580Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT05447078","phase":"PHASE3","title":"Spirulina Oral Supplement for Enhancing Host Resilience to Virus Infection","status":"COMPLETED","sponsor":"University of Mississippi Medical Center","startDate":"2022-07-01","conditions":"Healthy Volunteers","enrollment":492},{"nctId":"NCT05524532","phase":"PHASE3","title":"Effects of Immulina TM Supplements With PASC Patients","status":"COMPLETED","sponsor":"University of Mississippi Medical Center","startDate":"2023-07-20","conditions":"Post Acute COVID-19 Syndrome","enrollment":101},{"nctId":"NCT05556967","phase":"PHASE3","title":"Identification of Surrogate Blood and/or Urine Biomarker for Immulina TM (Trademark) in Normal Humans","status":"COMPLETED","sponsor":"University of Mississippi Medical Center","startDate":"2023-08-09","conditions":"Adherence, Patient","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Spirulina"],"phase":"phase_3","status":"active","brandName":"Immulina TM","genericName":"Immulina TM","companyName":"University of Mississippi Medical Center","companyId":"university-of-mississippi-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}